These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 29032079)

  • 1. Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies.
    Wu JHY; Marklund M; Imamura F; Tintle N; Ardisson Korat AV; de Goede J; Zhou X; Yang WS; de Oliveira Otto MC; Kröger J; Qureshi W; Virtanen JK; Bassett JK; Frazier-Wood AC; Lankinen M; Murphy RA; Rajaobelina K; Del Gobbo LC; Forouhi NG; Luben R; Khaw KT; Wareham N; Kalsbeek A; Veenstra J; Luo J; Hu FB; Lin HJ; Siscovick DS; Boeing H; Chen TA; Steffen B; Steffen LM; Hodge A; Eriksdottir G; Smith AV; Gudnason V; Harris TB; Brouwer IA; Berr C; Helmer C; Samieri C; Laakso M; Tsai MY; Giles GG; Nurmi T; Wagenknecht L; Schulze MB; Lemaitre RN; Chien KL; Soedamah-Muthu SS; Geleijnse JM; Sun Q; Harris WS; Lind L; Ärnlöv J; Riserus U; Micha R; Mozaffarian D;
    Lancet Diabetes Endocrinol; 2017 Dec; 5(12):965-974. PubMed ID: 29032079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality.
    Marklund M; Wu JHY; Imamura F; Del Gobbo LC; Fretts A; de Goede J; Shi P; Tintle N; Wennberg M; Aslibekyan S; Chen TA; de Oliveira Otto MC; Hirakawa Y; Eriksen HH; Kröger J; Laguzzi F; Lankinen M; Murphy RA; Prem K; Samieri C; Virtanen J; Wood AC; Wong K; Yang WS; Zhou X; Baylin A; Boer JMA; Brouwer IA; Campos H; Chaves PHM; Chien KL; de Faire U; Djoussé L; Eiriksdottir G; El-Abbadi N; Forouhi NG; Michael Gaziano J; Geleijnse JM; Gigante B; Giles G; Guallar E; Gudnason V; Harris T; Harris WS; Helmer C; Hellenius ML; Hodge A; Hu FB; Jacques PF; Jansson JH; Kalsbeek A; Khaw KT; Koh WP; Laakso M; Leander K; Lin HJ; Lind L; Luben R; Luo J; McKnight B; Mursu J; Ninomiya T; Overvad K; Psaty BM; Rimm E; Schulze MB; Siscovick D; Skjelbo Nielsen M; Smith AV; Steffen BT; Steffen L; Sun Q; Sundström J; Tsai MY; Tunstall-Pedoe H; Uusitupa MIJ; van Dam RM; Veenstra J; Monique Verschuren WM; Wareham N; Willett W; Woodward M; Yuan JM; Micha R; Lemaitre RN; Mozaffarian D; Risérus U;
    Circulation; 2019 May; 139(21):2422-2436. PubMed ID: 30971107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. n-6 fatty acid biomarkers and incident atrial fibrillation: an individual participant-level pooled analysis of 11 international prospective studies.
    Garg PK; Guan W; Nomura S; Weir NL; Tintle N; Virtanen JK; Hirakawa Y; Qian F; Sun Q; Rimm E; Lemaitre RN; Jensen PN; Heckbert SR; Imamura F; Steur M; Leander K; Laguzzi F; Voortman T; Ninomiya T; Mozaffarian D; Harris WS; Siscovick DS; Tsai MY;
    Am J Clin Nutr; 2023 Nov; 118(5):921-929. PubMed ID: 37769813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating omega-6 polyunsaturated fatty acids and total and cause-specific mortality: the Cardiovascular Health Study.
    Wu JH; Lemaitre RN; King IB; Song X; Psaty BM; Siscovick DS; Mozaffarian D
    Circulation; 2014 Oct; 130(15):1245-53. PubMed ID: 25124495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the Multi-Ethnic Study of Atherosclerosis.
    de Oliveira Otto MC; Wu JH; Baylin A; Vaidya D; Rich SS; Tsai MY; Jacobs DR; Mozaffarian D
    J Am Heart Assoc; 2013 Dec; 2(6):e000506. PubMed ID: 24351702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum n-6 polyunsaturated fatty acids, Δ5- and Δ6-desaturase activities, and risk of incident type 2 diabetes in men: the Kuopio Ischaemic Heart Disease Risk Factor Study.
    Yary T; Voutilainen S; Tuomainen TP; Ruusunen A; Nurmi T; Virtanen JK
    Am J Clin Nutr; 2016 May; 103(5):1337-43. PubMed ID: 27009754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acid biomarkers of dairy fat consumption and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies.
    Imamura F; Fretts A; Marklund M; Ardisson Korat AV; Yang WS; Lankinen M; Qureshi W; Helmer C; Chen TA; Wong K; Bassett JK; Murphy R; Tintle N; Yu CI; Brouwer IA; Chien KL; Frazier-Wood AC; Del Gobbo LC; Djoussé L; Geleijnse JM; Giles GG; de Goede J; Gudnason V; Harris WS; Hodge A; Hu F; ; Koulman A; Laakso M; Lind L; Lin HJ; McKnight B; Rajaobelina K; Risérus U; Robinson JG; Samieri C; Siscovick DS; Soedamah-Muthu SS; Sotoodehnia N; Sun Q; Tsai MY; Uusitupa M; Wagenknecht LE; Wareham NJ; Wu JH; Micha R; Forouhi NG; Lemaitre RN; Mozaffarian D;
    PLoS Med; 2018 Oct; 15(10):e1002670. PubMed ID: 30303968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte n-6 Polyunsaturated Fatty Acids, Gut Microbiota, and Incident Type 2 Diabetes: A Prospective Cohort Study.
    Miao Z; Lin JS; Mao Y; Chen GD; Zeng FF; Dong HL; Jiang Z; Wang J; Xiao C; Shuai M; Gou W; Fu Y; Imamura F; Chen YM; Zheng JS
    Diabetes Care; 2020 Oct; 43(10):2435-2443. PubMed ID: 32723842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-6 and N-3 fatty acid cholesteryl esters in relation to fatal CHD in a Dutch adult population: a nested case-control study and meta-analysis.
    de Goede J; Verschuren WM; Boer JM; Verberne LD; Kromhout D; Geleijnse JM
    PLoS One; 2013; 8(5):e59408. PubMed ID: 23741290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between omega-6 polyunsaturated fatty acids, hyperinsulinemia and incident diabetes by race/ethnicity: The Multi-Ethnic Study of Atherosclerosis.
    Weir NL; Nomura SO; Steffen BT; Guan W; Karger AB; Klein R; Klein BEK; Cotch MF; Tsai MY
    Clin Nutr; 2020 Oct; 39(10):3031-3041. PubMed ID: 32008872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies.
    Del Gobbo LC; Imamura F; Aslibekyan S; Marklund M; Virtanen JK; Wennberg M; Yakoob MY; Chiuve SE; Dela Cruz L; Frazier-Wood AC; Fretts AM; Guallar E; Matsumoto C; Prem K; Tanaka T; Wu JH; Zhou X; Helmer C; Ingelsson E; Yuan JM; Barberger-Gateau P; Campos H; Chaves PH; Djoussé L; Giles GG; Gómez-Aracena J; Hodge AM; Hu FB; Jansson JH; Johansson I; Khaw KT; Koh WP; Lemaitre RN; Lind L; Luben RN; Rimm EB; Risérus U; Samieri C; Franks PW; Siscovick DS; Stampfer M; Steffen LM; Steffen BT; Tsai MY; van Dam RM; Voutilainen S; Willett WC; Woodward M; Mozaffarian D;
    JAMA Intern Med; 2016 Aug; 176(8):1155-66. PubMed ID: 27357102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum n-6 polyunsaturated fatty acids and risk of death: the Kuopio Ischaemic Heart Disease Risk Factor Study.
    Virtanen JK; Wu JHY; Voutilainen S; Mursu J; Tuomainen TP
    Am J Clin Nutr; 2018 Mar; 107(3):427-435. PubMed ID: 29566193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of omega 3 polyunsaturated fatty acids with incident chronic kidney disease: pooled analysis of 19 cohorts.
    Ong KL; Marklund M; Huang L; Rye KA; Hui N; Pan XF; Rebholz CM; Kim H; Steffen LM; van Westing AC; Geleijnse JM; Hoogeveen EK; Chen YY; Chien KL; Fretts AM; Lemaitre RN; Imamura F; Forouhi NG; Wareham NJ; Birukov A; Jäger S; Kuxhaus O; Schulze MB; de Mello VD; Tuomilehto J; Uusitupa M; Lindström J; Tintle N; Harris WS; Yamasaki K; Hirakawa Y; Ninomiya T; Tanaka T; Ferrucci L; Bandinelli S; Virtanen JK; Voutilainen A; Jayasena T; Thalamuthu A; Poljak A; Bustamante S; Sachdev PS; Senn MK; Rich SS; Tsai MY; Wood AC; Laakso M; Lankinen M; Yang X; Sun L; Li H; Lin X; Nowak C; Ärnlöv J; Risérus U; Lind L; Le Goff M; Samieri C; Helmer C; Qian F; Micha R; Tin A; Köttgen A; de Boer IH; Siscovick DS; Mozaffarian D; Wu JH
    BMJ; 2023 Jan; 380():e072909. PubMed ID: 36653033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study.
    Forouhi NG; Imamura F; Sharp SJ; Koulman A; Schulze MB; Zheng J; Ye Z; Sluijs I; Guevara M; Huerta JM; Kröger J; Wang LY; Summerhill K; Griffin JL; Feskens EJ; Affret A; Amiano P; Boeing H; Dow C; Fagherazzi G; Franks PW; Gonzalez C; Kaaks R; Key TJ; Khaw KT; Kühn T; Mortensen LM; Nilsson PM; Overvad K; Pala V; Palli D; Panico S; Quirós JR; Rodriguez-Barranco M; Rolandsson O; Sacerdote C; Scalbert A; Slimani N; Spijkerman AM; Tjonneland A; Tormo MJ; Tumino R; van der A DL; van der Schouw YT; Langenberg C; Riboli E; Wareham NJ
    PLoS Med; 2016 Jul; 13(7):e1002094. PubMed ID: 27434045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. n-3 Fatty Acid Biomarkers and Incident Type 2 Diabetes: An Individual Participant-Level Pooling Project of 20 Prospective Cohort Studies.
    Qian F; Ardisson Korat AV; Imamura F; Marklund M; Tintle N; Virtanen JK; Zhou X; Bassett JK; Lai H; Hirakawa Y; Chien KL; Wood AC; Lankinen M; Murphy RA; Samieri C; Pertiwi K; de Mello VD; Guan W; Forouhi NG; Wareham N; Hu ICFB; Riserus U; Lind L; Harris WS; Shadyab AH; Robinson JG; Steffen LM; Hodge A; Giles GG; Ninomiya T; Uusitupa M; Tuomilehto J; Lindström J; Laakso M; Siscovick DS; Helmer C; Geleijnse JM; Wu JHY; Fretts A; Lemaitre RN; Micha R; Mozaffarian D; Sun Q;
    Diabetes Care; 2021 May; 44(5):1133-1142. PubMed ID: 33658295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-6 and trans fatty acids in blood cell membranes: a risk factor for acute coronary syndromes?
    Block RC; Harris WS; Reid KJ; Spertus JA
    Am Heart J; 2008 Dec; 156(6):1117-23. PubMed ID: 19033007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-6 and n-3 fatty acid cholesteryl esters in relation to incident stroke in a Dutch adult population: a nested case-control study.
    De Goede J; Verschuren WM; Boer JM; Kromhout D; Geleijnse JM
    Nutr Metab Cardiovasc Dis; 2013 Aug; 23(8):737-43. PubMed ID: 22633188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-6 and omega-3 fatty acids predict accelerated decline of peripheral nerve function in older persons.
    Lauretani F; Bandinelli S; Bartali B; Cherubini A; Iorio AD; Blè A; Giacomini V; Corsi AM; Guralnik JM; Ferrucci L
    Eur J Neurol; 2007 Jul; 14(7):801-8. PubMed ID: 17594339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study.
    Imamura F; Sharp SJ; Koulman A; Schulze MB; Kröger J; Griffin JL; Huerta JM; Guevara M; Sluijs I; Agudo A; Ardanaz E; Balkau B; Boeing H; Chajes V; Dahm CC; Dow C; Fagherazzi G; Feskens EJM; Franks PW; Gavrila D; Gunter M; Kaaks R; Key TJ; Khaw KT; Kühn T; Melander O; Molina-Portillo E; Nilsson PM; Olsen A; Overvad K; Palli D; Panico S; Rolandsson O; Sieri S; Sacerdote C; Slimani N; Spijkerman AMW; Tjønneland A; Tumino R; van der Schouw YT; Langenberg C; Riboli E; Forouhi NG; Wareham NJ
    PLoS Med; 2017 Oct; 14(10):e1002409. PubMed ID: 29020051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma eicosapentaenoic acid is negatively associated with all-cause mortality among men and women in a population-based prospective study.
    Miura K; Hughes MCB; Ungerer JP; Green AC
    Nutr Res; 2016 Nov; 36(11):1202-1209. PubMed ID: 27865614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.